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When rapid eye movement (REM) sleep occurs, noradrenergic cells become silent, with the
abolition of activity in locus coeruleus (LC) neurons seen as a key event permissive for the
occurrence of REM sleep. However, it is not known whether silencing of other than LC nora-
drenergic neurons contributes to the generation of REM sleep. In urethane-anesthetized
rats, stereotyped REM sleep-like episodes can be repeatedly elicited by injections of the
cholinergic agonist, carbachol, into a discrete region of the dorsomedial pons. We used
this preparation to test whether inhibition of ventrolateral pontine noradrenergic A5 neu-
rons only, or together with LC neurons, also can elicit REM sleep-like effects. To silence
noradrenergic cells, we sequentially injected the α2-adrenergic agonist clonidine (20–40 nl,
0.75 mM) into both A5 regions and then the LC. In two rats, successful bilateral clonidine
injections into the A5 region elicited the characteristic REM sleep-like episodes (hippocam-
pal theta rhythm, suppression of hypoglossal nerve activity, reduced respiratory rate). In
five rats, bilateral clonidine injections into the A5 region and then into one LC triggered REM
sleep-like episodes, and in two rats injections into both A5 and then both LC were needed
to elicit the effect. In contrast, in three rats, uni- or bilateral clonidine injections only into
the LC had no effect, and clonidine injections placed in another six rats outside of the A5
and/or LC regions were without effect. The REM sleep-like episodes elicited by clonidine
had similar magnitude of suppression of hypoglossal nerve activity (by 75%), similar pattern
of hippocampal changes, and similar durations (2.5–5.3 min) to the episodes triggered in
the same preparation by carbachol injections into the dorsomedial pontine reticular forma-
tion. Thus, silencing of A5 cells may importantly enable the occurrence of REM sleep-like
episodes, at least under anesthesia. This is a new role for noradrenergic A5 neurons.
Keywords: clonidine, carbachol, hippocampus, hypoglossal motoneurons, pons, REM sleep, respiratory rhythm,
theta rhythm
INTRODUCTION
The rapid eye movement (REM) stage of sleep is a state char-
acterized by wake-like cortical and hippocampal activation that
occurs in the absence of awareness of the external environment,
with tonic suppression of motor activity, random twitches of dis-
tal muscles, REMs, and distinct variability of breathing and blood
pressure (Aserinsky and Kleitman, 1953). The state is initiated
and orchestrated by a network of neurons located within the
brainstem, as indicated by the classic lesion and trans-section
experiments (Jouvet, 1962, 1994), but its occurrence is modu-
lated by descending inputs, especially those from the posterior
hypothalamus (Lin et al., 1989; Chemelli et al., 1999; Lu et al.,
2007). Single cell recordings from noradrenergic neurons of the
locus coeruleus (LC) and serotonergic neurons of the dorsal raphe
nucleus revealed that REM sleep is associated with the silencing
of these cells (McGinty and Harper, 1976; Trulson and Jacobs,
1979; Aston-Jones and Bloom, 1981) and concurrent activation
of a subset of dorsal pontine cholinergic neurons (El Mansari
et al., 1989; Steriade et al., 1990; Kayama et al., 1992; Thakkar
et al., 1998). Based on these data and the studies showing that
muscarinic cholinergic agonists delivered to the dorsomedial pon-
tine tegmentum trigger a REM sleep-like state (Silberman et al.,
1980; Baghdoyan et al., 1984; Kimura et al., 1990), a recipro-
cal model of the generation of REM sleep has been proposed
that had as its key feature direct or indirect mutually inhibitory
interactions between brainstem aminergic and cholinergic neu-
rons (McCarley and Hobson, 1975). In the original model and
its subsequent refinements, LC was seen as the key noradrener-
gic cell group whose silencing was necessary for the occurrence
of REM sleep (McCarley, 2004). Consistent with the reciprocal
interaction model, direct activation of LC neurons (Horvath et al.,
1999; Bourgin et al., 2000; Carter et al., 2010) and adrenergic drug
microinjections into the dorsal pontine tegmentum (Tononi et al.,
1991; Cirelli et al., 1992; Bier and McCarley, 1994) impede the
generation of REM sleep or abolish it altogether. However, lesions
of the LC had only small and transient effects on the amount
and pattern of REM sleep (Roussel et al., 1976; Webster and
Jones, 1988; Blanco-Centurion et al., 2004), suggesting that the
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absence of LC activity is not a key prerequisite for the occurrence
of REM sleep.
Recordings from noradrenergic cells of the pontine sub-
coeruleus region (Reiner, 1986) and the ventrolateral pontine A5
group (Fenik et al., 2002) revealed that, like LC neurons, these
cells are also silenced during REM sleep. In addition, indirect
evidence based on c-Fos immunohistochemistry suggested that
both pontine A7 neurons and medullary A2 neurons also have
reduced or abolished activity during REM sleep (Rukhadze et al.,
2008). Serotonergic neurons of the dorsal raphe nucleus and sero-
tonergic medullary neurons of the raphe obscurus and pallidus
nuclei are also silenced during REM sleep (Heym et al., 1982;
Woch et al., 1996). Whether silencing of all these neurons is neces-
sary for the occurrence of REM sleep has not been tested, nor were
any attempts made to determine whether any one of these groups
plays a particularly important permissive role in the generation of
REM sleep.
Over the years, we have extensively explored and validated
an acute model of REM sleep-like state based on urethane-
anesthetized rats. In this model, pontine microinjections of a
cholinergic agonist, carbachol, trigger a state that is electrophysio-
logically similar to REM sleep and comprises activation of cortical
EEG, generation of hippocampal theta-like rhythm, suppression of
motoneuronal activity, and silencing of noradrenergic cells of the
LC and A5 group (Kubin, 2001; Fenik et al., 2002, 2005; Fenik and
Kubin, 2009). These REM sleep-like episodes last 2–4 min and can
be elicited from the same site multiple times within the course of
an acute experiment (Fenik et al., 2004; Rukhadze et al., 2008).
As with natural REM sleep (Adamantidis et al., 2007), activa-
tion of cells in the wakefulness-promoting region of the posterior
hypothalamus abolishes the ability of pontine carbachol to elicit
REM sleep-like episodes in urethane-anesthetized rats (Lu et al.,
2007). Also as in chronically instrumented, behaving rats (Pollock
and Mistlberger, 2003; Sanford et al., 2003), dorsomedial pontine
injections of the GABAA receptor antagonist bicuculline trigger
REM sleep-like episodes in urethane-anesthetized rats (Fenik and
Kubin, 2009). These similarities demonstrate that important parts
of the neuronal network responsible for the generation of REM
sleep can be activated in a stereotyped manner under urethane
anesthesia.
In the present study, we tested whether inhibition of activity
in selected groups of pontine noradrenergic neurons elicits REM
sleep-like effects in urethane-anesthetized rats, thus activating the
brainstem REM sleep-generating network in a manner similar to
the way it is activated by dorsomedial pontine microinjections of
carbachol. We used microinjections of the α2-adrenergic agonist,
clonidine, to silence pontine noradrenergic neurons. Noradren-
ergic neurons of the A5 group are located within a well-defined
region of the caudal, ventrolateral pons between the lateral supe-
rior olivary nucleus and the roots of the seventh cranial nerve. To
date, they have been seen as important for cardiorespiratory con-
trol and modulation of nociception (Hilaire et al., 1989; Huangfu
et al., 1991; Clark and Proudfit, 1993; Erickson and Millhorn,
1994; Koshiya and Guyenet, 1994; Martin et al., 1999). How-
ever, A5 neurons also have efferent connections with brainstem
regions important for the control of sleep-wake states, includ-
ing the ventrolateral periaqueductal gray (Byrum and Guyenet,
1987; Kwiat and Basbaum, 1990), nucleus prepositus hypoglossi
(Iwasaki et al., 1999), dorsomedial pontine REM sleep-triggering
region (Semba, 1993), and medullary reticular paragigantocellu-
lar nucleus (van Bockstaele et al., 1989). In an earlier study (Fenik
et al., 2002), we observed that clonidine injections into the A5
region did not have any tonic effects on activity of hypoglossal
(XII) motoneurons or hippocampal activity but triggered in some
animals transient hippocampal and motoneuronal changes simi-
lar to the REM sleep-like episodes elicited by pontine carbachol.
Therefore, our goal was to investigate whether inhibition of pon-
tine A5 cells, with or without concurrent inhibition of LC neurons,
facilitates the occurrence REM sleep-like episodes in urethane-
anesthetized rats. A preliminary report has been published (Kubin
et al., 2003).
MATERIALS AND METHODS
ANIMAL PREPARATION
Experiments were performed on 16 adult, male Sprague-Dawley
rats [body weight: 376± 7 g (standard error – SE)] obtained from
Charles River Laboratories (Wilmington, MA, USA). All animal
procedures were approved by the Institutional Animal Care and
Use Committee of the University of Pennsylvania and followed the
guidelines for the care and use of experimental animals established
by the National Institutes of Health.
The animals were pre-anesthetized with isoflurane (2%) and
then anesthetized with urethane (1 g/kg, i.p., supplemented by
40 mg i.v. injections as needed). The trachea was intubated and
a femoral artery and vein were catheterized for arterial blood pres-
sure monitoring and fluid injections, respectively. The right XII
nerve was cut and its central end placed inside a cuff electrode
for recording (Fenik et al., 2001). The cervical vagi were cut to
enhance XII nerve activity and eliminate its reflex modulation by
pulmonary afferents. The head of the animal was placed in a stereo-
taxic holder, openings were made bilaterally in the interparietal
bone and the dura removed for inserting a drug-containing pipette
into the pons. Another opening was made for inserting a bipo-
lar recording electrode into the hippocampus. The electrode was
made from two Teflon insulated platinum wires (0.002′′/0.004′′
bare/coated diameter, A-M Systems, Carlsborg, WA, USA) with
tips separated by 0.8 mm and was inserted 3.7 mm posterior to
bregma, 2.2 mm to the right from midline and 2.4 mm below the
cortical surface. Two screws were attached to the skull (2 mm ante-
rior and 2 mm to the right, and 3 mm posterior and 2 mm to the
left, of bregma) to record the electroencephalogram (EEG).
The animals were paralyzed with pancuronium bromide
(2 mg/kg i.v., supplemented with 1 mg/kg injections as needed)
and artificially ventilated with a mixture of air and oxygen (30–
60% O2) at ∼50–60 lung inflations/min. After paralysis, the level
of anesthesia was assessed by intermittently applying a pinch to
the hind limb while recording the arterial blood pressure, EEG,
hippocampal, and XII nerve activity. Absence of pinch-induced
changes in either the respiratory rate or XII nerve activity and
only transient changes in blood pressure, EEG, and hippocampal
signals, similar to those before paralysis, indicated an adequate
level of anesthesia. Rectal temperature was maintained at 36–37˚C
throughout the experiments. The end-expiratory CO2 (Columbus
Instruments capnograph, Columbus, OH, USA) was adjusted at
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the beginning of the experiment to maintain a steady respiratory
modulation of XII nerve activity and then kept constant.
ELECTROPHYSIOLOGICAL RECORDINGS
Electroencephalogram (bandwidth 0.5–100 Hz), hippocampal
activity (2–20 Hz), XII nerve activity, and extracellularly recorded
single cell activity (30–2500 Hz) were amplified with AC amplifiers
(N101, Neurolog System; Digitimer, Hertfordshire, UK). The sig-
nals were continuously monitored on an 8-channel chart recorder
(TA-11; Gould Instruments, Valley View, OH, USA) and stored
using a 16-channel digital tape recorder (C-DAT; Cygnus Tech-
nology, Delaware Water Gap, PA, USA) together with tracheal
pressure,end-expiratory CO2, arterial blood pressure,and an event
marker. XII nerve activity was fed into a moving average cir-
cuit (MA-821 RSP; CWE, Inc., Ardmore, PA, USA; time constant:
100 ms).
DRUG MICROINJECTIONS
A glass pipette (A-M Systems) with a tip diameter of 25–30µm was
filled with the α2-adrenergic agonist clonidine (Sigma, St. Louis,
MO, USA; 0.75 mM in 0.9% NaCl prepared from frozen aliquots
before each experiment). In separate experiments, pipettes were
filled with carbamylcholine chloride (carbachol; Sigma; 10 mM
in 0.9% NaCl). Pontamine sky blue dye (2%, ICN Biomedicals,
Inc., Aurora, OH, USA) was added to these solutions to mark the
injection sites. Clonidine injections into the A5 region had a vol-
ume of 20–40 nl each, and those placed in the LC 20 nl. The target
stereotaxic coordinates for the A5 group were 9.8 mm posterior,
±2.7 mm lateral and 9.9 mm ventral relative to bregma, accord-
ing to a rat brain atlas (Paxinos and Watson, 1997). For the LC,
they were 9.7 mm posterior,±1.2 mm lateral, and 6.8 mm ventral.
Carbachol injection volumes were 10 nl; the locations of the effec-
tive injection sites were published previously (Fenik et al., 2005;
Fenik and Kubin, 2009). The drugs were injected over 10–30 s by
applying pressure to the fluid in the pipette while movement of the
meniscus was monitored with 2 nl resolution through a calibrated
microscope.
EXPERIMENTAL PROTOCOL
Once the animal was prepared for recording, at least three pen-
etrations were made with a tungsten recording microelectrode
(4–5µm tip exposure) to map out the location of one LC. LC cells
were recognized based on their firing rates at 1–5 Hz, a charac-
teristic configuration of their action potentials, brisk activation in
response to a noxious pinch of the hindlimb followed by a silent
period (Fenik et al., 2002), and location adjacent to large cells of
the mesencephalic trigeminal nucleus, which are strongly activated
by tactile stimuli applied to the muzzle region. Once the location
of one LC was established, the nominal coordinates for A5 and
LC described above were re-calculated relative to this site. This
approach allowed us to achieve proper placement of microinjec-
tions in A5 and, if needed, also LC in most animals, as subsequently
histologically verified.
After the mapping of LC location and allowing a 10-min period
to verify that all signals were stable, a clonidine-containing pipette
was inserted into the A5 region on one side and 20–40 nl of cloni-
dine solution were injected after an additional 60–90 s. The pipette
was then moved to the A5 region on the opposite side and another
injection made. In some experiments, if no changes occurred
within the next 4 min, the pipette was inserted into one LC and a
20-nl injection made. If this LC injection was also without effect,
an additional one was placed in the LC of the opposite side. Succes-
sive injections were separated on the average by 420± 25 s (range:
300–640 s), which allowed sufficient time to determine whether
any one of them initiated REM sleep-like, or any other, changes
in the recorded signals. If changes were noted within this time
frame, no further injections were made and observation contin-
ued until a recovery occurred from the effect of the last injection.
In three rats, injections were made only into the LC, without any
subsequent injections into the A5 regions. The reason for not con-
tinuing with A5 injections in these experiments was the evidence
that α2-adrenergic agonists injected into the dorsomedial pontine
tegmentum, which is located adjacent to the LC, inhibit the gen-
eration of REM sleep (Tononi et al., 1991) and the evidence that
cells located ventral to LC express α2-adrenergic receptors (Volgin
et al., 2009). A spread of clonidine from the LC to the adjacent dor-
somedial pontine reticular formation would likely occur over the
10–15 min needed to place additional injections in the A5 regions,
resulting in inhibition of dorsomedial pontine reticular neurons
essential for the generation of REM sleep. Therefore, injections
into the A5 region were not made when the LC was targeted first
because any negative results with subsequent clonidine injections
into the A5 regions would be inconclusive.
The amplitude of XII nerve activity and central respiratory rate
were measured from the moving average of nerve activity over
30–60 s control period prior to each injection and over another
30 s period centered on the peak of the response, if it occurred.
The onset and offset times of the effects were identified as the
times when a 10% decrease from baseline XII nerve activity and a
50% recovery occurred, respectively. For spectral analysis of the
EEG and hippocampal activity, the signals were digitized with
100 Hz sampling rate using Spike-2 software (Cambridge Elec-
tronics Design, UK) and the power spectrum was then calculated
within 0–20 Hz range over a 60- to 90-s control period and a 60-
to 90-s period centered on the peak of the effect.
HISTOLOGICAL VERIFICATION OF THE INJECTION SITES
At the conclusion of the experiment, the animal received an addi-
tional dose of urethane (1 g/kg, i.v.) and heparin (100 units) and
was intra-arterially perfused with cold 0.9% NaCl followed by
10% phosphate-buffered formalin. The brainstem was removed,
post-fixed in the same fixative, transferred to 30% sucrose and
then cut on a cryostat into 100µm coronal sections. All sections
containing Pontamine sky blue dye were serially mounted and
stained with Neutral red to localize the injection sites. The centers
of the injection sites were then transferred onto the nearest stan-
dard cross-sections from a rat brain atlas (Paxinos and Watson,
1997).
STATISTICAL ANALYSIS
After verification that the data were normally distributed, a two-
tailed paired Student’s t -test was used for comparison of measure-
ments taken at different times before and after clonidine injections
(SigmaStat, Jandel, Inc., San Rafael, CA, USA). The variability
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of the means is characterized by the SE throughout the report.
Differences were considered significant when p< 0.05.
RESULTS
REM SLEEP-LIKE EPISODES ELICITED BY CLONIDINE INJECTED INTO
THE A5 REGIONS, OR A5 REGIONS FOLLOWED BY LC
Figure 1 shows brain sections from one rat in which injections
were placed in all four sites, A5 bilaterally, and then LC bilaterally,
with the sites marked by deposits of Pontamine sky blue included
in the clonidine solution.
Figure 2 shows the locations of all clonidine injection sites
in all 16 animals. Each injection site is labeled with the ani-
mal number followed in parenthesis by the sequential number
of the injection and the total number of injections made in
this animal (up to 4, if both A5 regions and both LC were tar-
geted). In two rats, clonidine was successfully injected into the
A5 regions bilaterally (experiments 1 and 2; filled red circles). In
seven rats, successful injections were successively made into the
A5 regions bilaterally and then into one or both LC (experiments
3 through 9). In three rats, the A5 regions were targeted bilater-
ally but the centers of the injections were then found medial to
the A5 region (experiments 10–12; open red circles), and in three
rats, clonidine was injected into the LC only (experiments 14–
16; open blue circles). In the following description of our results,
we refer to the corresponding experiment numbers, as shown in
Figure 2.
Our goal was to investigate the ability of clonidine injections
into the A5 and LC to elicit REM sleep-like episodes as those
elicited by carbachol in urethane-anesthetized rats that we have
previously characterized as electrophysiologically analogous to
naturally occurring REM sleep (Fenik et al., 2002, 2005; Lu et al.,
2007; Fenik and Kubin, 2009; see Kubin, 2001; Kubin and Fenik,
2004 for reviews). Therefore, Figure 3 shows, for reference, a typi-
cal carbachol-elicited REM sleep-like episode during which we also
recoded from a LC neuron. Characteristic of the carbachol-elicited
REM sleep-like episodes are the gradual depression and then
recovery of inspiratory activity of the XII nerve accompanied by
slowing of the respiratory rate, appearance of a theta-like rhythm
in the hippocampus (3–4 Hz, when elicited under anesthesia;
Vertes et al., 1993), a rightward shift of the peak in EEG power spec-
trum, and often an elevation of EEG power in the 6–12 Hz range).
As shown in Figure 3, LC cells are silenced (Fenik et al., 1999;
Kubin, 2001), as are noradrenergic neurons of the A5 group (Fenik
et al., 2002). The carbachol-induced episodes maintain the same
characteristics when elicited repeatedly within the course of an
acute experiment, with only their duration typically varying from
2 to 4 min, and at most from 1.5 to 10 min (Rukhadze et al., 2008).
In two rats, REM sleep-like episodes with the same charac-
teristics as those produced by dorsomedial pontine injections of
carbachol occurred after bilateral clonidine injections into the A5
regions, and no additional injections were made in these animals
(experiments 1 and 2 in Figure 2). The episodes started 160–170 s
FIGURE 1 | Clonidine injection sites in the A5 and LC regions in one of
the rats that had injections made into all four sites, A5 bilaterally (top
panels) and LC bilaterally (bottom panels).The sites are marked with
Pontamine sky blue dye added to the clonidine solution. The injection
volumes were 30 nl per side for the A5 region and 20 nl per side for LC. In
the A5 region, most noradrenergic cells are located between the seventh
nerve (7 n) and the lateral superior olivary nucleus (LSO) and some also
occur along the dorsolateral border of the LSO (Fenik et al., 2002). Intense
blue staining marking the track of the injection pipette can be seen in the
bottom right and both top panels. The calibration bar in the top-right panel
applies to all panels. Abbreviations: 4V, 4th ventricle; PB, parabrachial
region.
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FIGURE 2 | Location of the sites of all clonidine injections made in this
study. Each symbol represents the center of a separate injection site, as
verified histologically from the location of Pontamine blue dye deposit (see
Figure 1). Injection sites were superimposed onto the closest standard
transverse brain section from a rat brain atlas (Paxinos and Watson, 1997) at
the indicated levels measured from bregma (B). Each injection site is marked
by the experiment (animal) number followed in parenthesis by the sequential
order of the injection and the total number of sites injected in this experiment.
Red filled and open circles correspond to the experiments in which clonidine
was injected first into the A5 regions bilaterally and then, in some animals,
also into the locus coeruleus (LC) uni- or bilaterally. Open blue circles
(Continued)
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FIGURE 2 | Continued
correspond to the three experiments in which clonidine was injected into
the LC only. Red filled circles indicate the experiments in which REM
sleep-like episode occurred following clonidine injections; open symbols
correspond to the experiments in which REM sleep-like episode did not
occur at the end of the injection sequence (all three experiments with
clonidine injections into the LC only and four experiments in which
clonidine was first injected into the A5 region bilaterally but the injections
were placed medial to the site where most noradrenergic A5 neurons are
located). The injection sites illustrated in Figure 1 correspond to
experiment 9 in this figure. Abbreviations: 7n, 7th cranial nerve; g7, genu
of the facial nerve; Mo5, trigeminal motor nucleus; LC, locus coeruleus;
LSO, lateral superior olivary nucleus; Mo7, facial motor nucleus; p,
pyramidal tract; PnC, nucleus pontis caudalis.
FIGURE 3 | A typical REM sleep-like episode elicited by carbachol
injection into the dorsomedial pontine tegmentum while recording
extracellularly from a noradrenergic cell of the LC. Characteristic of these
episodes are reduction of low-frequency components in favor of higher
frequencies (6–12 Hz) in the power spectrum of cortical
electroencephalogram (EEG), the appearance of theta-like rhythm in the
hippocampus (HIPP; 3–4 Hz under anesthesia; Vertes et al., 1993; c.f., graphs
at the bottom), reduction of inspiratory activity of the hypoglossal (XII) nerve,
and slowing of the respiratory rate. The top two traces show that, when these
changes occur, noradrenergic LC cells stop firing. The episodes typically last
2–4 min. The record was obtained in a related study (Fenik et al., 1999). XII
nerve trace shows integrated activity of the XII nerve, with each upward
deflection corresponding to the inspiratory phase of the central respiratory
cycle. The power spectra were calculated for a 60-s period of activity prior to
carbachol injection (open circles) and for a 60-s interval centered on the peak
of the response to carbachol (filled circles). Arrows point to the parts of the
spectra where differences can be noted between the control period and the
period of REM sleep-like episode.
after the onset of the second clonidine injection and lasted 150–
230 s. Figure 4 shows hippocampal, EEG, and XII nerve activities
recorded before and after the second of the two clonidine injection
and the power spectra of the cortical and hippocampal signals cal-
culated over 90 s intervals positioned before and at the peak of the
clonidine effect. In this rat (experiment 1 in Figure 2), XII nerve
activity was transiently abolished at the peak of the response, as is
also sometimes the case with the episodes elicited by pontine car-
bachol (Fenik et al., 2002, 2005; Fenik and Kubin, 2009). A gradual
slowing of the respiratory rate, from 40 to 30 min−1, is evident
prior to the disappearance of XII nerve activity.
In another five rats, within 7 min after bilateral clonidine
injections into the A5 regions that did not cause any changes,
a third clonidine injection was made into one LC (experiments
3 through 7 in Figure 2). In these rats, the third (LC) injec-
tion elicited a REM sleep-like episode. The effect started 72–240 s
(150± 33 s) after the injection into the LC and lasted 155–255 s
(204± 19 s). The inspiratory activity of the XII nerve was reduced
to 27–46% of the control level (34.6± 3.3%; p= 0.0004) and
the respiratory rate decreased by 5–28 min−1 (13.0± 4.1 min−1,
or from 46.8± 1.8 to 33.8± 5.0 min−1; p= 0.04). Figure 5
shows hippocampal, EEG, and XII nerve activities recorded
in one of these five rats before and after clonidine injection
into one LC that was preceded by bilateral clonidine injections
into the A5 regions that alone had no effect (experiment 3 in
Figure 2).
In an additional two rats, bilateral clonidine injections into both
A5 and LC were necessary to elicit the REM sleep-like episode, i.e.,
the episode occurred only after a clonidine injection into the LC
that was preceded by bilateral clonidine injections into the A5
regions and a clonidine injection into the LC on the opposite side
(experiments 8 and 9 in Figure 2). These episodes started 73–82 s
after the last injection and lasted 173–319 s. During one of them,
XII nerve activity was transiently abolished and during the other
one it was reduced to 55% of the control level, and respiratory rate
was reduced from 41 min−1 to less than 25 min−1 and from 44 to
34 min−1, respectively.
Figure 6 compares the average characteristics of all nine REM
sleep-like episodes elicited by clonidine injections into both A5
regions,with or without additional injections into the LC,obtained
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FIGURE 4 | A REM sleep-like episode triggered after clonidine was
injected into the A5 region on the left and then right side.The injection
marker shows the second of the two injections. Trace labels and figure format
are the same as for Figure 3. In this case, inspiratory activity of the XII nerve
was transiently abolished at the peak of the response. One can also note that
the central respiratory rate was reduced just before the disappearance of XII
nerve activity and just after it reappeared when compared with the
pre-injection period. The power spectra for the control period and the period
centered on the peak of the response are shown with open and filled circles,
respectively.
from nine rats in this study with the average effects of carba-
chol injections into the dorsomedial pons made in six urethane-
anesthetized, paralyzed and artificially ventilated rats in one of
our earlier studies (Fenik et al., 2005). The episodes elicited by
clonidine occurred with a significantly longer latency than those
triggered by carbachol, 137± 21 vs. 63± 26 s (Figure 6A). Other
than that, neither the episode duration (210± 19 vs. 185± 13 s;
Figure 6B), nor the magnitude of suppression of XII nerve activity
(to 25.3± 6.9% of the control level vs. 24.9± 3.6%; Figure 6C),
nor the reduction of the central respiratory rate (44.8± 1.3 to
32.6± 2.9 vs. 44.2± 2.1 to 34.5± 3.5 min−1; Figure 6D) were
significantly different. It is of note that, similar to the effects of dor-
somedial pontine carbachol injections, the REM sleep-like effects
elicited by clonidine injected into the A5 and LC regions were of
an all-or-none type; i.e., clonidine injections had no effect on the
EEG, hippocampal or XII nerve activity or respiratory rate unless
they elicited a stereotyped REM sleep-like episode.
CLONIDINE INJECTIONS INTO LC ONLY OR SITES ADJACENT TO THE A5
REGION DID NOT ELICIT REM SLEEP-LIKE EPISODES
In three rats, clonidine injections were placed into LC only, bilat-
erally in two, and unilaterally in one, animal (experiments 14, 15,
and 16 in Figure 2). None of these animals produced REM sleep-
like episodes. In another three rats, REM sleep-like episodes did
not occur when clonidine was injected aiming at both A5 regions
but subsequent histological verification indicated that the injec-
tions were placed medial to the A5 regions (experiments 10, 11,
and 12 in Figure 2). No additional injections were made in these
rats. In another rat, we intended to place clonidine injections into
the A5 region bilaterally and then into LC bilaterally but, for tech-
nical reasons, we missed all targets by 500–900µm (experiment 13
in Figure 2). Also in this rat no REM sleep-like effects occurred.
Thus, in two animals of the present study, bilateral injections that
properly hit the A5 region were sufficient to elicit REM sleep-like
episodes, in most experiments, bilateral clonidine injections into
the A5 region and into at least one LC were needed, whereas uni-
or bilateral injections into the LC only or into other than LC or A5
pontine sites were ineffective.
DISCUSSION
Although all studied to date noradrenergic neuronal groups of
the pons cease firing during REM sleep, it has not been deter-
mined whether all of them need to be silenced for the REM
sleep to occur. Alternatively, the silencing of some groups may
be necessary whereas the silencing of other groups may be not.
Traditionally, the LC has been seen as the key noradrenergic group
that has to cease firing for REM sleep to occur because it is the
most numerous group and because activation of LC neurons effec-
tively suppresses generation of REM sleep. The results of our study
do not contradict the findings that activation of LC neurons can
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FIGURE 5 | A REM sleep-like episode triggered after clonidine was
injected into the A5 regions bilaterally and then into the right LC.
The injection marker shows the LC injection only. Trace labels and figure
format are the same as for Figure 3. Note the similarity of the changes
elicited here by clonidine to those elicited by carbachol and illustrated in
Figure 3. The power spectra for the control period and the period
centered on the peak of the response are shown with open and filled
circles, respectively.
FIGURE 6 | Comparison of the average characteristics of the REM
sleep-like episodes elicited by clonidine injections into theA5 regions,
with or without additional injections into the LC, and those elicited
by carbachol injections into the dorsomedial pontine tegmentum.The
episodes elicited by clonidine occurred with a significantly longer latency
than those elicited by carbachol (A). Other than that, neither the episode
duration (B), nor the magnitude of suppression of XII nerve activity (C),
nor the reduction of the central respiratory rate (D) were significantly
different between the episodes elicited by clonidine and carbachol. The
bars show a comparison of the average data from nine REM sleep
(REMS)-like episodes elicited by clonidine in nine rats in this study and
average data from six REMS-like episodes elicited by pontine carbachol
(10 nl, 10 mM) in six rats of one of our previous studies (Fenik et al., 2005).
The significance levels shown in (C,D) refer to the differences between the
measurements taken prior to and during the REMS-like episode. NS, not
statistically significant.
effectively suppress REM sleep, but they point to an important per-
missive role of the silencing of noradrenergic A5 neurons. To date,
A5 neurons have been proposed to contribute to cardiorespiratory
regulation and nociception, whereas their role as an important
part of the brainstem network responsible for the generation of
REM sleep has not been considered. Based on our results, we pro-
pose that silencing of noradrenergic A5 neurons is necessary for
the occurrence of REM sleep.
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Our results support an important permissive role of A5 neurons
in the generation of REM sleep because of the following. In two
experiments, we observed that bilateral clonidine injections into
the A5 regions were sufficient to initiate REM sleep-like episodes
in our rat model, whereas REM sleep-like episodes did not occur
in any of the three rats in which clonidine was injected into the
LC only and in another three rats in which only A5 regions were
targeted but the injections were placed too medial. Furthermore,
in most other rats, REM sleep-like episodes were triggered when
clonidine was properly placed bilaterally into the A5 regions and
into only one LC. Since in these experiments LC activity on the
opposite side was not pharmacologically inhibited, one must con-
clude that the persistence of LC activity on the intact side was not
sufficient to prevent generation of the REM sleep-like episodes
when A5 neurons were bilaterally inhibited. This is rather remark-
able if one considers that the LC contains nearly five times more
noradrenergic neurons that the A5 group (Rukhadze and Kubin,
2007) and that the compact size of the LC makes it relatively easier
to deliver clonidine by microinjection to all its neurons than to
achieve the same for the A5 group due to its considerably larger
antero-posterior and medio-lateral dimensions.
The urethane-anesthetized rat offers an attractive model with
which to study the effects of various manipulations that remove
selected inputs that are normally associated with wakefulness or
arousal and oppose the occurrence of REM sleep. In urethane-
anesthetized rats, dorsomedial pontine injections of carbachol
readily induce REM sleep-like episodes (Kubin, 2001; Fenik et al.,
2004, 2005; Lu et al., 2007; Fenik and Kubin, 2009), whereas, in
unanesthetized, behaving rats, carbachol is less effective (Gnadt
and Pegram, 1986; Okabe et al., 1998; Boissard et al., 2002). The
difference may be due to concomitant REM sleep-suppressing
cholinergic effects exerted in adjacent reticular regions and/or
suprapontine influences that act to oppose cholinergic trigger-
ing of REM sleep in rats (Taguchi et al., 1992; Bourgin et al.,
1995; Okabe et al., 1998; discussed by Kubin, 2001). Indeed, anes-
thetics may activate some of the same neuronal groups that are
also activated during natural non-REM sleep (Lu et al., 2008) and
deactivate certain cholinergic and GABAergic neurons in a manner
analogous to that observed during non-REM sleep (Vanini et al.,
2011). This may then favor activation of the brainstem network
responsible for the generation of REM sleep. Occasionally, some
urethane-anesthetized rats in our studies spontaneously generate
REM sleep-like episodes like those elicited by dorsomedial pontine
carbachol (or bicuculline) injections and like those observed in the
present study following clonidine injections. Such spontaneous
episodes, not related to any obvious external triggering event, are
relatively rare but may occur more frequently following multiple
pontine carbachol injections (Rukhadze et al., 2008). Thus, the
urethane-anesthetized rats have an inherently high propensity to
enter a REM sleep-like state. At the same time, this propensity
probably varies among the preparations due to a host of subtle
factors (e.g., level of anesthesia or brain perfusion). This variabil-
ity may be the reason why, in some animals of the present study,
silencing of A5 neurons only was sufficient to elicit REM sleep-like
episodes, whereas in other rats inhibition of LC neurons on at least
one side was needed to achieve this effect. Our present data show
that activity of pontine noradrenergic neurons, including those
of the A5 group, acts against spontaneous occurrence of REM
sleep-like episodes in urethane-anesthetized rats.
The hypothesis that the silencing of LC neurons is a key factor
enabling the occurrence of REM sleep has been previously ques-
tioned on the basis of limited decrements of c-Fos expression in
LC neurons following periods of enhanced REM sleep produced as
a result of prior REM sleep deprivation (Leger et al., 2009). Based
on those findings, the authors suggested that the silencing of other
noradrenergic neurons may be more important. Our results sug-
gest that the A5 group is particularly important,which is somewhat
unexpected because cardiorespiratory control and modulation of
nociception are the main functions ascribed to A5 neurons (Sagen
and Proudfit, 1986; Hilaire et al., 1989; Huangfu et al., 1991; Clark
and Proudfit, 1993; Erickson and Millhorn, 1994; Koshiya and
Guyenet, 1994; Martin et al., 1999; Bajic and Commons, 2010).
Supportive of these functions are the descending projections of A5
neurons to the intermediolateral cell column of the thoracic spinal
cord and the ventrolateral medullary A1 region (Loewy et al., 1979,
1986; Westlund et al., 1983; Byrum and Guyenet, 1987; Clark and
Proudfit, 1993; Howorth et al., 2009; Marques-Lopes et al., 2010).
It is, however, of note that other projections of A5 neurons target
brainstem regions that are strongly associated with the control of
sleep-wake states, such as the dorsal raphe nucleus (Peyron et al.,
1996), ventrolateral periaqueductal gray (Byrum and Guyenet,
1987; Kwiat and Basbaum, 1990), nucleus prepositus hypoglossi
(Iwasaki et al., 1999), dorsomedial pontine REM sleep-triggering
region (Semba, 1993), and medullary reticular paragigantocellular
nucleus (van Bockstaele et al., 1989). Furthermore, some A5 neu-
rons have ascending projections to the paraventricular nucleus of
the hypothalamus (Byrum and Guyenet, 1987) and paucisynaptic
connections to the CA1 region of the hippocampus (Castle et al.,
2005). Many of these connections are reciprocal, and many paral-
lel similar connections of the LC. Through these connections A5
neurons may play an important role in the control of behavioral
states.
Based on our results, we cannot exclude that clonidine injected
into the A5 region facilitated the occurrence of REM sleep-
like episodes through its actions on non-noradrenergic neurons
located within, or adjacent to, the A5 region. However, there
is currently no evidence for the presence in the A5 region of
non-noradrenergic neurons that would have afferent and effer-
ent connections appropriate for interaction with other brainstem
regions important for the generation of REM sleep. Only the nora-
drenergic neurons located in the A5 region consistently express the
inhibitory α2A-adrenergic receptors and are inhibited by low doses
of clonidine (Byrum et al., 1984; Guyenet et al., 1994; Koshiya and
Guyenet, 1994; Fenik et al., 2002). Furthermore, the REM sleep-
like episodes were facilitated in our study only when clonidine
injections were properly placed within the A5 region. In three rats
in which clonidine was injected bilaterally medial to the region
containing most noradrenergic A5 neurons (experiments 10–12
in Figure 2), REM sleep-like episodes did not occur. Also, cloni-
dine injections like those conducted in the present study targeting
the noradrenergic A7 group located in the lateral pons did not
elicit REM sleep-like episodes (Fenik et al., 2008). Thus, the REM
sleep-like effects observed in our present study were dependent on
the presence of clonidine-receptive neurons and occurred when
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the injections were properly placed into the A5 region. This leaves
little room for the possibility that inhibition of some not yet
identified non-noradrenergic neurons located in the ventrolateral
pons facilitated the occurrence of REM sleep-like episodes in our
experiments.
The comparison of the different characteristics of the REM
sleep-like episodes triggered by clonidine injected into the A5
and LC regions and carbachol injected into the dorsomedial pons
(Figure 6) revealed that only the latency of the effect was sig-
nificantly longer for clonidine than for carbachol. The reason
for this may be our use of a rather low concentration of cloni-
dine (0.75 vs. 10 mM for carbachol), a slightly higher molecular
weight of clonidine than carbachol (230 vs. 183 g) which would
cause slower diffusion, and also the volume of tissue occupied
by noradrenergic A5 neurons which is probably larger than the
carbachol-sensitive region in the dorsolateral pons (Fenik and
Kubin, 2009). Other than the latency difference, the REM sleep-like
episodes were nearly identical, suggesting that both clonidine and
carbachol only triggered the REM sleep-like episodes, whereas
their pattern and duration were controlled and orchestrated by
a common brainstem REM sleep-generating neuronal network.
CONCLUSION
Although the A5 group has not been implicated to date in the
regulation of REM sleep, our results suggest that the silencing of
noradrenergic A5 neurons is necessary for the generation of this
state. Thus, the connections between A5 neurons and other brain-
stem neuronal groups involved in the generation of REM sleep
need to be investigated in order to better understand the role of
A5 neurons in the regulation of sleep-wake states.
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